查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1854768

动物疼痛管理市场按动物类型、产品类型、给药途径、最终用户和分销管道划分－2025-2032年全球预测

Veterinary Pain Management Market by Animal Type, Product Type, Route Of Administration, End User, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，兽医疼痛管理市场将成长至 44.7 亿美元，复合年增长率为 10.09%。

关键市场统计数据
基准年 2024 20.7亿美元
预计年份：2025年 22.8亿美元
预测年份 2032 44.7亿美元
复合年增长率 (%) 10.09%

一个全面的框架，阐述了正在重新定义跨物种和跨医疗机构兽医疼痛管理实践的临床和商业性动态。

随着临床医生、生产商和经销商积极应对不断变化的动物健康重点、法律规范和客户期望，兽医疼痛管理领域正在迅速转型。药理学的进步、多模态镇痛的兴起以及对动物福利日益增长的关注，正在重塑伴侣动物、马匹和农场动物的照护通讯协定。同时，技术赋能的诊断和数位疗法也开始影响疼痛的评估和管理方式，为临床工作流程的整合创造了新的机会。

决策者不仅需要了解产品层面的创新，还需要了解给药方式、用药偏好和终端使用者采购管道的变化。本报告整合了临床、商业和分销动态，全面展现了当前的实践和新兴的压力。对治疗模式、给药途径和医务人员采纳行为的重点分析，揭示了对产品开发、监管沟通和商业策略的实际启示。转型背景将临床需求与市场机会连结起来，并为后续的策略考量奠定了基础。

药理学、给药方法和分销管道的创新如何重塑兽用镇痛药的临床方案和商业策略

由于科学创新、监管调整和相关人员期望的转变，兽医镇痛领域正在经历变革。非类固醇消炎剂的进步、局部麻醉剂配方的改进以及人们对鸦片类药物管理的重新关注，正在改变临床治疗流程。同时，给药途径的进步，例如长效注射剂和经皮製剂，正在扩大镇痛药的覆盖范围并提高其依从性，尤其是在门诊病人和居家医疗环境中。

在商业方面，随着数位药局和直接面向消费者模式的日益普及，分销管道日益碎片化，迫使製造商重新思考其通路策略和病患支援服务。兽医医院和诊所正在发展成为更完善的医疗中心，需要全面的产品支援、培训和循证通讯协定。这种多方力量的融合正在重塑竞争格局和市场开发方法，促进药理学家、医疗器材动态和兽医之间的多学科合作，共同开发符合日益提高的疗效、安全性和动物福利标准的解决方案。

评估美国在2025年宣布或实施的关税对供应链、采购和临床连续性的连锁影响

美国2025年可能加征关税的前景将对兽医疼痛管理领域的相关人员产生多方面的影响，包括供应链、采购成本和策略采购决策。依赖全球生产网路采购活性原料药、辅料和成品製​​剂的製造商可能面临更高的到岸成本和前置作业时间延长，促使他们寻求供应商多元化或重新评估近岸外包方案。对于契约製造製造商和经销商而言，进口关税的增加可能会压缩利润空间，促使他们精简营运并与通路合作伙伴重新谈判条款。

诊所和医院在采购专有或特殊配方药物时，可能会遇到采购摩擦，因为经销商将增加的成本转嫁给客户或调整库存政策。为此，采购方可能会寻求长期采购协议、寻找替代学名药或增加国内库存以缓解短期波动。此外，监管、海关和文件方面的负担可能会增加行政成本并延迟产品上市。这些动态共同凸显了情境规划、供应链分析以及与物流合作伙伴积极沟通的重要性，以确保医疗服务的连续性和关键疼痛治疗药物的可近性。

以细分市场主导的策略要务阐明了物种、治疗层级、给药途径、最终用户和分销管道的选择将如何影响临床应用和商业性定位。

透过市场区隔获得的洞察揭示了不同动物种类、产品类别、给药途径、最终用户和通路在临床和商业性行为方面的差异。按动物类型（猫、狗、马和牲畜）分析，镇痛药物类别的使用模式因物种特异性的动态、给药复杂性和客户期望而异，从而推动了差异化的产品开发和标籤策略。在产品类型内部，局部麻醉剂、非类固醇消炎剂和鸦片类药物之间的差异揭示了监管审查、管理考虑和临床适应症的差异。在非类固醇消炎剂类别中，卡洛芬、氟尼辛、美洛昔康和罗贝考昔等药物之间又存在进一步的区分，每种药物都具有独特的安全性特征和兽医处方偏好。

依给药途径（注射、口服、局部和经皮）进行细分，突显了以使用者为中心的权衡因素，例如起效时间、持续时间和给药便利性。注射剂又细分为肌肉注射、静脉注射和皮下注射，以适应不同的治疗环境和患者接受度；局部剂型包括凝胶、贴片和喷雾剂，可支持居家给药和局部治疗。终端用户细分体现了线上药局、研究机构、零售药局、兽医诊所和动物医院等不同机构的采购週期、合规要求和服务期望如何影响商业性合作。最后，按分销管道（直销、医院药房、线上药房和零售药房）进行细分，阐明了上市途径的选择如何影响定价、促销和产品支援方面的投入，凸显了针对不同管道製定价值提案和伙伴关係模式的必要性。

美洲、欧洲、中东和非洲以及亚太地区的监管、临床和分销方面的细微差别会影响市场准入和商业化策略。

美洲、欧洲、中东和非洲以及亚太地区的市场动态差异显着，不同的法律规范、临床实务模式和供应链结构都会影响产品的存取和商业化。在美洲，诊所间更紧密的整合以及数位化采购的普及提高了效率，同时，消费者对配套服务和培训支援的期望也在不断提高。此外，监管路径往往更倾向于已建立的药物安全检测体系，这体现在上市后监测策略中。

在欧洲、中东和非洲，不同的法规和报销模式要求采取量身定制的监管和市场策略，同时，对兽医教育和动物福利标准的持续投入也推动了对循证镇痛方案的需求。亚太地区基础设施快速发展，兽医服务网络不断扩展，但各地生产能力参差不齐，这促使企业与区域经销商建立合作关係，并投资于扎根于当地的供应链。要成功利用这些区域差异，需要采取适应性强的监管策略、符合当地文化的行销策略以及能够协调全球产品标准与当地市场实际情况的分销模式。

医药和动物用药品之间的竞争动态和策略行动正在塑造以证据、服务和管道为中心的差异化。

动物疼痛管理领域的竞争格局呈现出多元化的特点，既有成熟的製药企业，也有专注于动物用药品的公司，还有不断研发新配方和给药系统的创新企业。领导企业透过优先提供可靠的临床证据、针对兽医专业人员进行有针对性的教育和推广活动，以及加大对产品安全监测的投入，来打造差异化优势。为了寻求在配方科学、分销网络或当地监管专业知识方面的互补能力，战略联盟和许可协议十分常见。

产品差异化越来越依赖良好的耐受性、简化的给药方案或在实际应用中展现出的显着优势，而提供培训模组、剂量计算器和客户教育材料等综合支援服务的公司则获得了更深入的临床应用。竞争定位也体现在通路选择：有些公司强调与医院药局和兽医诊所的合作，而有些公司则专注于零售和线上药局的销售，以吸引註重便利性的终端用户。这些发展趋势为寻求开拓细分市场的专业参与企业创造了机会，而大型公司则透过丰富的产品组合和深入的服务来巩固其市场地位。

製造商和经销商可以采取切实可行的策略步骤，以增强供应韧性、促进临床医生采用产品并优化管道特定的商业性策略。

产业领导者应采取一系列切实可行的措施，以增强韧性，加速差异化治疗方法的推广应用，并使商业模式与不断发展的临床实践相适应。首先，製造商和经销商应实施全面的供应链映射和双源筹资策略，以降低关税波动和原物料短缺带来的风险。其次，投资兽医专业人员和客户的多药镇痛教育，有助于循证处方，并透过可验证的疗效和更高的用药依从性来提升产品价值。

第三，优先开发以使用者为中心的剂型，例如长效注射剂和经皮贴剂，可以解决用药依从性问题，并改善不同动物物种的患者福利。第四，企业应根据兽医诊所、医院、零售药局和线上平台的具体需求，量身订做通路策略，提供差异化的商业性奖励和服务组合。最后，积极与监管机构沟通并加强上市后监测，可以降低安全隐患，并促进产品更快被市场接受。总而言之，这些措施使企业能够在应对竞争压力的同时，为临床医生和动物饲主带来切实可见的益处。

透过严谨的混合方法研究途径，结合专家访谈、临床文献综合和基于情境的供应链分析，获得可操作的洞见。

本分析的调查方法结合了定性专家访谈、系统文献综述以及监管指南和临床实践资源的综合分析，以确保各相关人员的观点平衡。主要资讯来源包括与执业兽医、药理学家、监管专家和分销主管进行的结构化咨询，以了解实际决策因素、治疗偏好和采购惯例。次要资讯来源则依赖同侪审查的临床研究、药理学教科书和官方监管文件，以检验主要镇痛药及其给药平台的安全性、剂量注意事项和标籤说明。

此分析方法结合了跨细分市场映射和基于情境的供应链压力测试，以评估脆弱性和应对方案。透过对一手访谈和二手资料进行三角验证，减少了偏差，提高了主题结论的稳健性。必要时，也进行了敏感度分析，以检验关税引发的成本压力、通路转移以及新管理实务的采用所带来的影响。这种混合调查方法框架既能提供可操作的洞见，又能保持方法论的透明度和可重复性。

整合策略重点，使临床创新、监管预期和商业性韧性保持一致，从而改善兽医疼痛护理和组织绩效。

总之，兽医疼痛管理领域正处于曲折点，临床创新、不断变化的经销管道以及宏观经济压力正在交汇融合，重新定义机会与风险。积极整合供应链韧性、投资于临床医生教育、并根据物种和环境特定需求调整产品和渠道策略的利益相关者，将更有利于改善患者预后并获得商业性优势。监管相关人员、给药途径偏好和终端用户采购行为之间的相互作用，要求制定一项将临床证据与切实可行的市场推广策略相结合的协作策略。

随着市场不断发展，各机构应优先考虑适应性规划、合作伙伴关係以及对上市后证据的持续投入，以支持产品的长期认可和信任。聚焦这些策略支柱将使公司和护理机构能够应对短期挑战，同时朝着提高伴侣动物、马匹和牲畜疼痛管理标准的目标迈进。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 在小动物临床实务中推广整合非类固醇抗发炎药、鸦片类药物和局部麻醉剂的多模态镇痛通讯协定
  • 使用长效注射止痛药进行马术后疼痛管理
  • 利用穿戴式感测器技术客观监测宠物疼痛和活动
  • 远端医疗和远距诊疗平台在伴侣动物慢性疼痛评估的普及
  • 将富血小板血浆和干细胞等再生疗法应用于关节疼痛治疗
  • 开发包括经皮神经电刺激（TENS）和针灸在内的非阿片类神经调节技术用于猫的慢性疼痛管理。
  • 针对犬猫发炎疼痛途径的新兴物种特异性单株抗体
  • 在兽医患者中，人们越来越关注透过基因生物标誌物和精准给药进行个人化疼痛管理。

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依动物类型分類的动物疼痛管理市场

  • 猫
  • 狗
  • 马
  • 家畜

9. 依产品类型分類的动物疼痛管理市场

  • 局部麻醉剂
  • 非类固醇消炎剂
    • 卡洛芬
    • 氟尼辛
    • 美洛昔康
    • 罗贝那昔布
  • 阿片类药物

第十章 依给药途径分類的动物疼痛管理市场

  • 注射
    • 肌肉内注射
    • 静脉
    • 皮下
  • 口服
  • 话题
    • 凝胶
    • 修补
    • 喷
  • 经皮

第十一章：按最终用户分類的动物疼痛管理市场

  • 网路药房
  • 研究机构
  • 零售药房
  • 兽医诊所
  • 兽医诊所

第十二章：按通路分類的动物疼痛管理市场

  • 直销
  • 医院药房
  • 网路药房
  • 零售药房

第十三章 动物疼痛管理市场：依地区划分

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章：依组别分類的动物疼痛管理市场

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国动物疼痛管理市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Zoetis Inc.
    • Elanco Animal Health Incorporated
    • Merck & Co., Inc.
    • Boehringer Ingelheim International GmbH
    • Dechra Pharmaceuticals PLC
    • Ceva Sante Animale SA
    • Vetoquinol SA
    • Norbrook Laboratories Limited
    • Virbac SA
    • Phibro Animal Health Corporation
Product Code: MRR-957C47F93EAD

The Veterinary Pain Management Market is projected to grow by USD 4.47 billion at a CAGR of 10.09% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 2.07 billion
Estimated Year [2025] USD 2.28 billion
Forecast Year [2032] USD 4.47 billion
CAGR (%) 10.09%

Comprehensive framing of clinical and commercial dynamics redefining veterinary pain management practices across species and care settings

The veterinary pain management landscape is undergoing rapid transformation as clinicians, manufacturers, and distributors respond to evolving animal health priorities, regulatory frameworks, and client expectations. Advances in pharmacology, a shift toward multimodal analgesia, and heightened attention to animal welfare are reshaping protocols across companion, equine, and production animal practice. At the same time, technology-enabled diagnostics and digital therapeutics are beginning to influence how pain is assessed and managed, creating new opportunities for integration across clinical workflows.

Decision-makers must understand not only product-level innovations but also changes in delivery modalities, administration preferences, and end-user procurement pathways. This report synthesizes clinical, commercial, and distributional dynamics to provide a consolidated view of current practice and emergent pressures. By focusing on treatment modalities, administration routes, and practitioner adoption behaviors, the analysis highlights actionable implications for product development, regulatory engagement, and commercial strategy. Transitional context links clinical need to market opportunity and frames the strategic considerations that follow.

How innovations in pharmacology, delivery methods, and distribution channels are jointly reshaping clinical protocols and commercial strategies in veterinary analgesia

The landscape for veterinary analgesia is experiencing transformative shifts driven by scientific innovation, regulatory recalibration, and changing stakeholder expectations. Advances in nonsteroidal anti-inflammatory agents, refinement of local anesthetic formulations, and renewed attention to opioid stewardship are altering therapeutic algorithms in clinical practice. Concurrently, progress in routes of administration-such as long-acting injectables and transdermal delivery systems-enables extended analgesic coverage and improved compliance, particularly in outpatient or home-care environments.

On the commercial side, distribution channels are fragmenting as digital pharmacies and direct-to-consumer models gain traction, prompting manufacturers to reassess channel strategies and patient support services. Veterinary clinics and hospitals are evolving into more sophisticated care hubs that demand integrated product support, training, and evidence-based protocols. These converging forces are incentivizing cross-disciplinary collaborations among pharmacologists, device developers, and veterinary practitioners to co-develop solutions that meet rising standards for efficacy, safety, and animal welfare, thereby reshaping competitive dynamics and go-to-market approaches.

Evaluating the cascading supply chain, procurement, and clinical continuity effects stemming from United States tariff measures announced or implemented in 2025

The prospect of tariffs introduced by the United States in 2025 carries multifaceted implications for veterinary pain management stakeholders, affecting supply chains, procurement costs, and strategic sourcing decisions. Manufacturers that rely on global manufacturing networks for active pharmaceutical ingredients, excipients, or finished formulations may face higher landed costs and disrupted lead times, prompting a reassessment of supplier diversification and nearshoring options. For contract manufacturers and distributors, greater import duties can compress margins and incentivize operational efficiencies or renegotiated commercial terms with channel partners.

Clinics and hospitals that procure proprietary or specialized formulations may experience procurement friction as distributors pass through cost increases or adjust inventory policies. In response, buyers could pursue longer-term purchase agreements, seek alternative generics, or increase onshore stockpiling to mitigate short-term volatility. Additionally, regulatory compliance, customs processing, and documentation burdens could introduce administrative overheads that slow product introductions. Collectively, these dynamics underscore the importance of scenario planning, supply chain mapping, and proactive engagement with logistics partners to preserve continuity of care and maintain access to critical analgesic therapies.

Segment-driven strategic imperatives showing how species, therapeutic class, administration route, end user, and distribution choices shape clinical adoption and commercial positioning

Insights derived from segmentation illuminate distinct clinical and commercial behaviors across animal type, product class, administration route, end user, and distribution pathways. When analyzed by animal type-cats, dogs, equine, and livestock-adoption patterns for analgesic classes diverge due to species-specific pharmacodynamics, dosing complexity, and client expectations, driving differentiated product development and labeling strategies. Within product type segmentation, distinctions among local anesthetics, nonsteroidal anti-inflammatory drugs, and opioids reveal varying regulatory scrutiny, stewardship considerations, and clinical indications; the nonsteroidal anti-inflammatory category further differentiates around agents such as carprofen, flunixin, meloxicam, and robenacoxib, each associated with unique safety profiles and veterinary prescribing preferences.

Route of administration segmentation-injectable, oral, topical, and transdermal-highlights user-centric trade-offs between onset, duration, and ease of administration; injectable options subdivide into intramuscular, intravenous, and subcutaneous approaches tailored to care setting and patient tolerance, while topical applications encompass gels, patches, and sprays that support at-home management or localized therapy. End user segmentation captures how online pharmacies, research institutes, retail pharmacies, veterinary clinics, and veterinary hospitals impose different procurement cycles, compliance requirements, and service expectations that shape commercial engagement. Finally, distribution channel segmentation-direct distribution, hospital pharmacies, online pharmacies, and retail pharmacies-illustrates how route-to-market choices influence pricing, promotional focus, and product support investments, underscoring the need for channel-specific value propositions and partnership models.

Regional regulatory, clinical practice, and distribution nuances across the Americas, Europe Middle East & Africa, and Asia-Pacific that influence access and commercialization strategies

Regional dynamics vary substantially across the Americas, Europe Middle East & Africa, and Asia-Pacific, each presenting distinct regulatory frameworks, clinical practice patterns, and supply chain architectures that influence product access and commercialization. In the Americas, practice consolidation among clinics and increasing use of digital procurement create efficiencies but also raise expectations for bundled service offerings and training support; regulatory pathways tend to favor well-established pharmacovigilance systems, which informs post-market surveillance strategies.

Across Europe, the Middle East & Africa, regulatory heterogeneity and divergent reimbursement models require tailored regulatory and market access approaches, while growing investments in veterinary education and welfare standards are driving demand for evidence-based analgesic protocols. The Asia-Pacific region exhibits rapid infrastructure development, expanding veterinary service networks, and variable local manufacturing capacity, which together incentivize partnerships with regional distributors and investments in localized supply chain resilience. Navigating these regional nuances calls for adaptive regulatory strategy, culturally attuned marketing, and distribution models that reconcile global product standards with local market realities.

Competitive dynamics and strategic behaviours among pharmaceutical and specialty animal health companies shaping differentiation through evidence, services, and channel focus

The competitive landscape in veterinary pain management is characterized by a mix of established pharmaceutical manufacturers, specialty animal health companies, and agile innovators developing new formulations and delivery systems. Leading organizations prioritize robust clinical evidence generation, targeted educational outreach to veterinary professionals, and investments in product safety monitoring to differentiate their offerings. Strategic collaborations and licensing agreements are common as companies seek complementary capabilities in formulation science, distribution networks, or regional regulatory expertise.

Product differentiation increasingly depends on demonstrating superior tolerability, simplified dosing regimens, or clear advantages in real-world settings, while companies that offer integrated support services-such as training modules, dosing calculators, and client education materials-achieve deeper clinical engagement. Competitive positioning also reflects decisions about channel focus; some companies emphasize partnerships with hospital pharmacies and veterinary hospitals for high-touch engagement, whereas others optimize for retail and online pharmacy distribution to capture convenience-driven end users. These dynamics create openings for specialized entrants to capture niche segments while larger firms consolidate presence through portfolio breadth and service depth.

Actionable strategic measures for manufacturers and distributors to fortify supply resilience, accelerate clinician adoption, and optimize channel-specific commercial approaches

Industry leaders should pursue a set of pragmatic actions that strengthen resilience, accelerate adoption of differentiated therapies, and align commercial models with evolving clinical practice. First, manufacturers and distributors need to execute comprehensive supply chain mapping and dual-sourcing strategies to reduce exposure to tariff-driven disruptions and raw material shortages. Second, investing in multimodal analgesia education for veterinary professionals and clients will support evidence-based prescribing and enhance product value through demonstrable outcomes and adherence improvements.

Third, prioritizing development of user-centric administration formats-such as long-acting injectables or transdermal patches-can address adherence challenges and improve patient welfare across species. Fourth, companies must tailor channel strategies to meet the distinct needs of veterinary clinics, hospitals, retail pharmacies, and online platforms, offering differentiated commercial incentives and service bundles. Finally, proactive regulatory engagement and robust post-market surveillance will mitigate safety concerns and support faster market acceptance; collectively, these measures will enable organizations to respond to competitive pressures while delivering measurable benefits to clinicians and animal owners.

Rigorous mixed-method research approach combining expert interviews, clinical literature synthesis, and scenario-based supply chain analysis to produce actionable insights

The research methodology underpinning this analysis integrates qualitative expert interviews, systematic literature review, and synthesis of regulatory guidance and clinical practice resources to ensure balanced perspectives across stakeholders. Primary inputs included structured consultations with practicing veterinarians, pharmacologists, regulatory specialists, and distribution executives to capture real-world decision drivers, therapeutic preferences, and procurement practices. Secondary inputs relied on peer-reviewed clinical studies, pharmacology texts, and public regulatory documentation to validate safety profiles, administration considerations, and labeling implications for key analgesic agents and delivery platforms.

Analytical approaches combined cross-segmentation mapping with scenario-based supply chain stress testing to evaluate vulnerabilities and response options. Triangulation between primary interviews and secondary sources was applied to reduce bias and enhance the robustness of thematic conclusions. Where appropriate, sensitivity analyses were used to examine the implications of tariff-induced cost pressures, channel shifts, and adoption of new administration modalities. This mixed-method framework supports actionable insights while preserving methodological transparency and reproducibility.

Synthesis of strategic priorities that reconcile clinical innovation, regulatory expectations, and commercial resilience to advance veterinary pain care and organizational performance

In conclusion, the veterinary pain management sector is at an inflection point where clinical innovation, distribution evolution, and macroeconomic pressures converge to redefine opportunity and risk. Stakeholders that proactively integrate supply chain resilience, invest in clinician education, and tailor product and channel strategies to species- and setting-specific needs will be best positioned to deliver improved patient outcomes and secure commercial advantage. The interplay between regulatory expectations, administration route preferences, and end-user procurement behaviors demands coordinated strategies that align clinical evidence with pragmatic go-to-market tactics.

As markets continue to evolve, organizations should prioritize adaptive planning, collaborative partnerships, and sustained investment in post-market evidence generation to support long-term acceptance and trust. By focusing on these strategic pillars, companies and care providers can navigate near-term disruptions while advancing toward higher standards of pain management across companion, equine, and livestock populations.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Expansion of multimodal analgesia protocols integrating NSAIDs, opioids, and local anesthetics in small animal practice
  • 5.2. Adoption of long acting injectable analgesic formulations for equine postoperative pain management
  • 5.3. Implementation of wearable sensor technology for objective pain and mobility monitoring in pets
  • 5.4. Surge in telemedicine and remote consultation platforms for chronic pain assessment in companion animals
  • 5.5. Integration of regenerative therapies such as platelet rich plasma and stem cells for joint pain
  • 5.6. Development of non opioid neuromodulation techniques including TENS and acupuncture for feline chronic pain management
  • 5.7. Emergence of species specific monoclonal antibodies targeting inflammatory pain pathways in dogs and cats
  • 5.8. Increasing focus on personalized pain management driven by genomic biomarkers and precision dosing in veterinary patients

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Veterinary Pain Management Market, by Animal Type

  • 8.1. Cats
  • 8.2. Dogs
  • 8.3. Equine
  • 8.4. Livestock

9. Veterinary Pain Management Market, by Product Type

  • 9.1. Local Anesthetics
  • 9.2. Nonsteroidal Anti-Inflammatory Drugs
    • 9.2.1. Carprofen
    • 9.2.2. Flunixin
    • 9.2.3. Meloxicam
    • 9.2.4. Robenacoxib
  • 9.3. Opioids

10. Veterinary Pain Management Market, by Route Of Administration

  • 10.1. Injectable
    • 10.1.1. Intramuscular
    • 10.1.2. Intravenous
    • 10.1.3. Subcutaneous
  • 10.2. Oral
  • 10.3. Topical
    • 10.3.1. Gels
    • 10.3.2. Patches
    • 10.3.3. Sprays
  • 10.4. Transdermal

11. Veterinary Pain Management Market, by End User

  • 11.1. Online Pharmacies
  • 11.2. Research Institutes
  • 11.3. Retail Pharmacies
  • 11.4. Veterinary Clinics
  • 11.5. Veterinary Hospitals

12. Veterinary Pain Management Market, by Distribution Channel

  • 12.1. Direct Distribution
  • 12.2. Hospital Pharmacies
  • 12.3. Online Pharmacies
  • 12.4. Retail Pharmacies

13. Veterinary Pain Management Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Veterinary Pain Management Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Veterinary Pain Management Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Zoetis Inc.
    • 16.3.2. Elanco Animal Health Incorporated
    • 16.3.3. Merck & Co., Inc.
    • 16.3.4. Boehringer Ingelheim International GmbH
    • 16.3.5. Dechra Pharmaceuticals PLC
    • 16.3.6. Ceva Sante Animale S.A.
    • 16.3.7. Vetoquinol S.A.
    • 16.3.8. Norbrook Laboratories Limited
    • 16.3.9. Virbac S.A.
    • 16.3.10. Phibro Animal Health Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS VETERINARY PAIN MANAGEMENT MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE VETERINARY PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST VETERINARY PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN VETERINARY PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC VETERINARY PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION VETERINARY PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS VETERINARY PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 VETERINARY PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO VETERINARY PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. VETERINARY PAIN MANAGEMENT MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. VETERINARY PAIN MANAGEMENT MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. VETERINARY PAIN MANAGEMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY CATS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY CATS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY CATS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY CATS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY CATS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY CATS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DOGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DOGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DOGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DOGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DOGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DOGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY EQUINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY EQUINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY EQUINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY EQUINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY EQUINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY EQUINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY LIVESTOCK, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY LIVESTOCK, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY LIVESTOCK, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY LIVESTOCK, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY LIVESTOCK, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY LOCAL ANESTHETICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY LOCAL ANESTHETICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY LOCAL ANESTHETICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY LOCAL ANESTHETICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY LOCAL ANESTHETICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY LOCAL ANESTHETICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY CARPROFEN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY CARPROFEN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY CARPROFEN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY CARPROFEN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY CARPROFEN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY CARPROFEN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY FLUNIXIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY FLUNIXIN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY FLUNIXIN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY FLUNIXIN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY FLUNIXIN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY FLUNIXIN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY MELOXICAM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY MELOXICAM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY MELOXICAM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY MELOXICAM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY MELOXICAM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY MELOXICAM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROBENACOXIB, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROBENACOXIB, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROBENACOXIB, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROBENACOXIB, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROBENACOXIB, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROBENACOXIB, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INJECTABLE, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INJECTABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INJECTABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INTRAMUSCULAR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INTRAMUSCULAR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INTRAMUSCULAR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INTRAMUSCULAR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY SUBCUTANEOUS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY SUBCUTANEOUS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY SUBCUTANEOUS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY SUBCUTANEOUS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ORAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ORAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ORAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ORAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TOPICAL, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TOPICAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TOPICAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TOPICAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TOPICAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TOPICAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY GELS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY GELS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY GELS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY GELS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY GELS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY GELS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PATCHES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PATCHES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PATCHES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PATCHES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PATCHES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PATCHES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY SPRAYS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY SPRAYS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY SPRAYS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY SPRAYS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY SPRAYS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY SPRAYS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TRANSDERMAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TRANSDERMAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TRANSDERMAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TRANSDERMAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TRANSDERMAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY VETERINARY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY VETERINARY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY VETERINARY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY VETERINARY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY VETERINARY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY VETERINARY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY VETERINARY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY VETERINARY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DIRECT DISTRIBUTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DIRECT DISTRIBUTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DIRECT DISTRIBUTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DIRECT DISTRIBUTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DIRECT DISTRIBUTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DIRECT DISTRIBUTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 203. AMERICAS VETERINARY PAIN MANAGEMENT MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 204. AMERICAS VETERINARY PAIN MANAGEMENT MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 205. AMERICAS VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 206. AMERICAS VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 207. AMERICAS VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 208. AMERICAS VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 209. AMERICAS VETERINARY PAIN MANAGEMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2024 (USD MILLION)
  • TABLE 210. AMERICAS VETERINARY PAIN MANAGEMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2025-2032 (USD MILLION)
  • TABLE 211. AMERICAS VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 212. AMERICAS VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 213. AMERICAS VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
  • TABLE 214. AMERICAS VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INJECTABLE, 2025-2032 (USD MILLION)
  • TABLE 215. AMERICAS VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
  • TABLE 216. AMERICAS VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TOPICAL, 2025-2032 (USD MILLION)
  • TABLE 217. AMERICAS VETERINARY PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 218. AMERICAS VETERINARY PAIN MANAGEMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 219. AMERICAS VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 220. AMERICAS VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 221. NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 224. NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 225. NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 226. NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 227. NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2024 (USD MILLION)
  • TABLE 228. NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2025-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 230. NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
  • TABLE 232. NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INJECTABLE, 2025-2032 (USD MILLION)
  • TABLE 233. NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
  • TABLE 234. NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TOPICAL, 2025-2032 (USD MILLION)
  • TABLE 235. NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 236. NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 237. NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 238. NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 239. LATIN AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. LATIN AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. LATIN AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 242. LATIN AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 243. LATIN AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. LATIN AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 245. LATIN AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2024 (USD MILLION)
  • TABLE 246. LATIN AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2025-2032 (USD MILLION)
  • TABLE 247. LATIN AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 248. LATIN AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 249. LATIN AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
  • TABLE 250. LATIN AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INJECTABLE, 2025-2032 (USD MILLION)
  • TABLE 251. LATIN AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
  • TABLE 252. LATIN AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TOPICAL, 2025-2032 (USD MILLION)
  • TABLE 253. LATIN AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 254. LATIN AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 255. LATIN AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 256. LATIN AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INJECTABLE, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TOPICAL, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE, MIDDLE EAST & AFRICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE, MIDDLE EAST & AFRICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPE VETERINARY PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE VETERINARY PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPE VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPE VETERINARY PAIN MANAGEMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPE VETERINARY PAIN MANAGEMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPE VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INJECTABLE, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPE VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPE VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TOPICAL, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPE VETERINARY PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPE VETERINARY PAIN MANAGEMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 293. MIDDLE EAST VETERINARY PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 294. MIDDLE EAST VETERINARY PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 295. MIDDLE EAST VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 296. MIDDLE EAST VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 297. MIDDLE EAST VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 298. MIDDLE EAST VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 299. MIDDLE EAST VETERINARY PAIN MANAGEMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2024 (USD MILLION)
  • TABLE 300. MIDDLE EAST VETERINARY PAIN MANAGEMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2025-2032 (USD MILLION)
  • TABLE 301. MIDDLE EAST VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 302. MIDDLE EAST VETERINARY PAIN MANAGEMENT MARKET S